Extent Research Assistant ×
📩 [email protected] | 📞 +1 (212) 951-1369

Request Sample/Pricing Details:

💬
Extent Research Global Atosiban Market
REPORT DETAILS FREE ANALYSIS INQUIRY FOR BUYING REQUEST SAMPLE
Home / Pharma & Healthcare / Global Atosiban Market

Global Atosiban Market

Comprehensive industry overview, market size, share, trends, and forecast analysis.

Pharma & Healthcare Feb 2019 Global 350 Pages No of Tables: 220 No of Figures: 60 Reviewed By: Priya M Author: Julie
Request for TOC Speak to Analyst Inquire Before Buying Download Free Sample PDF

Global Atosiban Market

Market Size in USD Billion

CAGR : 17.60%
USD 1.14
2025
USD 4.17
2033
Forecast Period 2025 - 2033
Market Size (Base Year) USD 1.14 Billion
Market Size (Forecast) USD 4.17 Billion
CAGR 17.60%
Major Market Players Data provided in full report

Extent Research has published a market study on the global Atosiban market. The report incorporates the complete ecosystem of the Atosiban industry along with the key market players Ferring Pharmaceuticals, Sun Pharma, Shanghai Soho-Yiming Pharmaceuticals, EVER Pharma, Hangzhou Longshine Bio-Tech, Cayman Chemical, Neore Pharmaceutical, in the market. The global Atosiban market report covers the fundamental overview of the market which includes introduction, diverse segmentation, and financial structure. Furthermore, the market research report also focuses on providing the necessary business strategies, competitive landscape, new product launches, and key demographic areas to better understand the market status on the global platform.

Data provided by Extent Research. Source: https://www.extentresearch.com/atosiban-market

There is a section in the report that encompasses the industrial players thriving in the market. Some of the key players include Ferring Pharmaceuticals, Sun Pharma, Shanghai Soho-Yiming Pharmaceuticals, EVER Pharma, Hangzhou Longshine Bio-Tech, Cayman Chemical, Neore Pharmaceutical, . The research report also touches upon the vital information including market size, share, revenue, supply & demand chain, and market strategies to give a complete review of the market expansion. The Atosiban market report has majority of the business policies and market strategies provided to help increase the survival of the market on the global platform.

All the information provided in the global Atosiban market report are thoroughly verified using primary & secondary sources as well as the use of certain research tools or methodologies. Moreover, the detailing of the market challenges, threats, opportunities, and market growth will probably give the interested companies to gain better knowledge about the Atosiban market.

Segmentation of the Global Atosiban Market:

By Product type

  • Injection, Concentrate,

by Application

  • Hospital Pharmacies, Online Pharmacies,

Reasons to purchase the global Atosiban market report:

  • Innovative market development trends and marketing channels are provided
  • Overall market feasibility and growth rate over the foreseeable time is concluded
  • Accurate mentioning of statistical data and valuable source for directing interested companies
  • Study on development policies & plans, manufacturing processes, and costing gives a better idea about import/export consumption, supply & demand, pricing, revenue, and gross margins.
  • Competitive landscape and demographic analysis provides a clear picture of the market status on the international platform
  • Availability of customization as per the requirement

Report Scope and Market Segmentation

ATTRIBUTES Global Atosiban Market KEY MARKET INSIGHTS
Segments Covered
  • By Product Type: All Products Type Includes
  • By Application: All Application Type Includes
  • By End User: All End User Type Includes
  • By Distribution Channel: All Distribution Channel Includes
Countries Covered
  • North America
    • U.S., Canada, Mexico
  • Europe
    • Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe
  • Asia-Pacific
    • China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific
  • Latin America
    • Brazil, Argentina, Rest of Latin America
  • Middle East & Africa
    • Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players
  • Leading Tier 1 Corporations
  • Prominent Regional Manufacturers
  • Emerging Market Disruptors
  • Technology Integrators & Suppliers
  • *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities
  • Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability.
  • Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands.
  • Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities.
  • Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry.
  • Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...
Read more about Julie
Priya M

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...
Learn more about Priya M
BASIC ATTRIBUTES | KEY MARKET INSIGHTS
Report Title Global Atosiban Market
Base Year 2025
Forecast Period 2025 - 2033
Market Size (Base) USD 1.14 Billion
Projected Size USD 4.17 Billion
CAGR 17.60%

Table of Contents

1 Study Coverage 1.1 Atosiban Product Introduction 1.2 Market by Type 1.2.1 Global Atosiban Market Size Growth Rate by Type, 2017 VS 2021 VS 2035 1.2.2 Injection 1.2.3 Concentrate 1.3 Market by Application 1.3.1 Global Atosiban Market Size Growth Rate by Application, 2017 VS 2021 VS 2035 1.3.2 Hospital Pharmacies 1.3.3 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Atosiban Sales Estimates and Forecasts 2017-2035 2.2 Global Atosiban Revenue Estimates and Forecasts 2017-2035 2.3 Global Atosiban Revenue by Region: 2017 VS 2021 VS 2035 2.4 Global Atosiban Sales by Region 2.4.1 Global Atosiban Sales by Region (2017-2022) 2.4.2 Global Sales Atosiban by Region (2023-2035) 2.5 Global Atosiban Revenue by Region 2.5.1 Global Atosiban Revenue by Region (2017-2022) 2.5.2 Global Atosiban Revenue by Region (2023-2035) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Atosiban Sales by Manufacturers 3.1.1 Global Top Atosiban Manufacturers by Sales (2017-2022) 3.1.2 Global Atosiban Sales Market Share by Manufacturers (2017-2022) 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Atosiban in 2021 3.2 Global Atosiban Revenue by Manufacturers 3.2.1 Global Atosiban Revenue by Manufacturers (2017-2022) 3.2.2 Global Atosiban Revenue Market Share by Manufacturers (2017-2022) 3.2.3 Global Top 10 and Top 5 Companies by Atosiban Revenue in 2021 3.3 Global Atosiban Sales Price by Manufacturers (2017-2022) 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Atosiban Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Atosiban Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Atosiban Sales by Type 4.1.1 Global Atosiban Historical Sales by Type (2017-2022) 4.1.2 Global Atosiban Forecasted Sales by Type (2023-2035) 4.1.3 Global Atosiban Sales Market Share by Type (2017-2035) 4.2 Global Atosiban Revenue by Type 4.2.1 Global Atosiban Historical Revenue by Type (2017-2022) 4.2.2 Global Atosiban Forecasted Revenue by Type (2023-2035) 4.2.3 Global Atosiban Revenue Market Share by Type (2017-2035) 4.3 Global Atosiban Price by Type 4.3.1 Global Atosiban Price by Type (2017-2022) 4.3.2 Global Atosiban Price Forecast by Type (2023-2035) 5 Market Size by Application 5.1 Global Atosiban Sales by Application 5.1.1 Global Atosiban Historical Sales by Application (2017-2022) 5.1.2 Global Atosiban Forecasted Sales by Application (2023-2035) 5.1.3 Global Atosiban Sales Market Share by Application (2017-2035) 5.2 Global Atosiban Revenue by Application 5.2.1 Global Atosiban Historical Revenue by Application (2017-2022) 5.2.2 Global Atosiban Forecasted Revenue by Application (2023-2035) 5.2.3 Global Atosiban Revenue Market Share by Application (2017-2035) 5.3 Global Atosiban Price by Application 5.3.1 Global Atosiban Price by Application (2017-2022) 5.3.2 Global Atosiban Price Forecast by Application (2023-2035) 6 North America 6.1 North America Atosiban Market Size by Type 6.1.1 North America Atosiban Sales by Type (2017-2035) 6.1.2 North America Atosiban Revenue by Type (2017-2035) 6.2 North America Atosiban Market Size by Application 6.2.1 North America Atosiban Sales by Application (2017-2035) 6.2.2 North America Atosiban Revenue by Application (2017-2035) 6.3 North America Atosiban Market Size by Country 6.3.1 North America Atosiban Sales by Country (2017-2035) 6.3.2 North America Atosiban Revenue by Country (2017-2035) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Atosiban Market Size by Type 7.1.1 Europe Atosiban Sales by Type (2017-2035) 7.1.2 Europe Atosiban Revenue by Type (2017-2035) 7.2 Europe Atosiban Market Size by Application 7.2.1 Europe Atosiban Sales by Application (2017-2035) 7.2.2 Europe Atosiban Revenue by Application (2017-2035) 7.3 Europe Atosiban Market Size by Country 7.3.1 Europe Atosiban Sales by Country (2017-2035) 7.3.2 Europe Atosiban Revenue by Country (2017-2035) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Atosiban Market Size by Type 8.1.1 Asia Pacific Atosiban Sales by Type (2017-2035) 8.1.2 Asia Pacific Atosiban Revenue by Type (2017-2035) 8.2 Asia Pacific Atosiban Market Size by Application 8.2.1 Asia Pacific Atosiban Sales by Application (2017-2035) 8.2.2 Asia Pacific Atosiban Revenue by Application (2017-2035) 8.3 Asia Pacific Atosiban Market Size by Region 8.3.1 Asia Pacific Atosiban Sales by Region (2017-2035) 8.3.2 Asia Pacific Atosiban Revenue by Region (2017-2035) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Atosiban Market Size by Type 9.1.1 Latin America Atosiban Sales by Type (2017-2035) 9.1.2 Latin America Atosiban Revenue by Type (2017-2035) 9.2 Latin America Atosiban Market Size by Application 9.2.1 Latin America Atosiban Sales by Application (2017-2035) 9.2.2 Latin America Atosiban Revenue by Application (2017-2035) 9.3 Latin America Atosiban Market Size by Country 9.3.1 Latin America Atosiban Sales by Country (2017-2035) 9.3.2 Latin America Atosiban Revenue by Country (2017-2035) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Atosiban Market Size by Type 10.1.1 Middle East and Africa Atosiban Sales by Type (2017-2035) 10.1.2 Middle East and Africa Atosiban Revenue by Type (2017-2035) 10.2 Middle East and Africa Atosiban Market Size by Application 10.2.1 Middle East and Africa Atosiban Sales by Application (2017-2035) 10.2.2 Middle East and Africa Atosiban Revenue by Application (2017-2035) 10.3 Middle East and Africa Atosiban Market Size by Country 10.3.1 Middle East and Africa Atosiban Sales by Country (2017-2035) 10.3.2 Middle East and Africa Atosiban Revenue by Country (2017-2035) 10.3.3 Turkey 10.3.4 Saudi Arabia 11 Company Profiles 11.1 Ferring Pharmaceuticals 11.1.1 Ferring Pharmaceuticals Corporation Information 11.1.2 Ferring Pharmaceuticals Overview 11.1.3 Ferring Pharmaceuticals Atosiban Sales, Price, Revenue and Gross Margin (2017-2022) 11.1.4 Ferring Pharmaceuticals Atosiban Product Model Numbers, Pictures, Descriptions and Specifications 11.1.5 Ferring Pharmaceuticals Recent Developments 11.2 Sun Pharma 11.2.1 Sun Pharma Corporation Information 11.2.2 Sun Pharma Overview 11.2.3 Sun Pharma Atosiban Sales, Price, Revenue and Gross Margin (2017-2022) 11.2.4 Sun Pharma Atosiban Product Model Numbers, Pictures, Descriptions and Specifications 11.2.5 Sun Pharma Recent Developments 11.3 Shanghai Soho-Yiming Pharmaceuticals 11.3.1 Shanghai Soho-Yiming Pharmaceuticals Corporation Information 11.3.2 Shanghai Soho-Yiming Pharmaceuticals Overview 11.3.3 Shanghai Soho-Yiming Pharmaceuticals Atosiban Sales, Price, Revenue and Gross Margin (2017-2022) 11.3.4 Shanghai Soho-Yiming Pharmaceuticals Atosiban Product Model Numbers, Pictures, Descriptions and Specifications 11.3.5 Shanghai Soho-Yiming Pharmaceuticals Recent Developments 11.4 EVER Pharma 11.4.1 EVER Pharma Corporation Information 11.4.2 EVER Pharma Overview 11.4.3 EVER Pharma Atosiban Sales, Price, Revenue and Gross Margin (2017-2022) 11.4.4 EVER Pharma Atosiban Product Model Numbers, Pictures, Descriptions and Specifications 11.4.5 EVER Pharma Recent Developments 11.5 Hangzhou Longshine Bio-Tech 11.5.1 Hangzhou Longshine Bio-Tech Corporation Information 11.5.2 Hangzhou Longshine Bio-Tech Overview 11.5.3 Hangzhou Longshine Bio-Tech Atosiban Sales, Price, Revenue and Gross Margin (2017-2022) 11.5.4 Hangzhou Longshine Bio-Tech Atosiban Product Model Numbers, Pictures, Descriptions and Specifications 11.5.5 Hangzhou Longshine Bio-Tech Recent Developments 11.6 Cayman Chemical 11.6.1 Cayman Chemical Corporation Information 11.6.2 Cayman Chemical Overview 11.6.3 Cayman Chemical Atosiban Sales, Price, Revenue and Gross Margin (2017-2022) 11.6.4 Cayman Chemical Atosiban Product Model Numbers, Pictures, Descriptions and Specifications 11.6.5 Cayman Chemical Recent Developments 11.7 Neore Pharmaceutical 11.7.1 Neore Pharmaceutical Corporation Information 11.7.2 Neore Pharmaceutical Overview 11.7.3 Neore Pharmaceutical Atosiban Sales, Price, Revenue and Gross Margin (2017-2022) 11.7.4 Neore Pharmaceutical Atosiban Product Model Numbers, Pictures, Descriptions and Specifications 11.7.5 Neore Pharmaceutical Recent Developments 12 Industry Chain and Sales Channels Analysis 12.1 Atosiban Industry Chain Analysis 12.2 Atosiban Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Atosiban Production Mode & Process 12.4 Atosiban Sales and Marketing 12.4.1 Atosiban Sales Channels 12.4.2 Atosiban Distributors 12.5 Atosiban Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Atosiban Industry Trends 13.2 Atosiban Market Drivers 13.3 Atosiban Market Challenges 13.4 Atosiban Market Restraints 14 Key Findings in The Global Atosiban Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst
TESTIMONIALS

What our clients say about us ?

★★★★★

"The standard report was strong from the beginning. What truly added value was the collaboration with the researchers we could openly discuss market insights and request additional data and analyses over several rounds."

Client

Michael Heidecker

Founder and Managing Director

★★★★★

"Extent Research delivered exactly what we needed reliable data, competitive pricing, and outstanding support. Their team was responsive, collaborative, and enhanced the report with custom insights every step of the way."

Client

Dr. Bernd Binder

Product Manager

★★★★★

"Super quick and helpful support even during the holidays! I really appreciated the effort. The report quality was excellent, with clear details and great insights that helped me understand the progress easily. Thank you so much!"

Client

Ryoko Tanaka

Head of Planning Dept

Top Brands That Trust Us

×
Julie
View Profile

Julie

Head of Research & Multidisciplinary Strategist

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly balances analytical rigor with sharp business acumen. Throughout her impressive career, she has evolved from a dedicated research analyst into a visionary leader who specializes in decoding complex market dynamics, analyzing competitive landscapes, and identifying emerging global trends. Her primary mission is to transform raw, intricate data into forward-looking strategies and actionable intelligence that empower stakeholders to make highly informed, strategic decisions.

Data provided by Extent Research. Source: https://www.extentresearch.com/atosiban-market

Under her expert leadership, the team at Extent Research consistently delivers top-tier insights across an incredibly diverse array of international sectors. Whenever she oversees the development of a comprehensive Market Research Report, she ensures that it meticulously covers the specific nuances of the client’s target industry. Her multidisciplinary approach allows her to seamlessly integrate economic indicators and industry intelligence across vast domains. Her remarkable portfolio of sector expertise spans foundational global industries like Agriculture, Chemical & Material, Machinery & Equipment, Automobile & Transportation, Energy & Power, and Aerospace and Defense. Furthermore, she provides critical strategic oversight in fast-paced consumer and tech markets, including Consumer Goods, Food & Beverages, Packaging, Electronics & Semiconductor, Internet & Communication, New Technology, and Service & Software. Her expansive analytical reach also deeply penetrates life sciences and wellness fields, delivering precise data for Medical Care, Medical Devices & Consumables, and Pharma & Healthcare.

Recognized industry-wide for designing highly effective, customized research methodologies, Julie brings a uniquely visionary approach to strategic consulting. She integrates deep data analysis with a macro-economic perspective, ensuring that every piece of industry intelligence is fully utilized to drive meaningful business transformations. Her exceptional ability to work fluidly across so many complex sectors gives her clients a distinct competitive advantage in highly saturated markets. Ultimately, Julie Jayne’s leadership is the driving force behind Extent Research’s unwavering commitment to delivering elite, actionable insights, proving her to be an invaluable asset to organizations looking to navigate the future of global commerce.

Domain Assigned: Multiple Sectors
×
Priya M
View Profile

Priya M

Vice President

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives with highly tailored, research-backed solutions. She brings a wealth of strategic experience to the table, ensuring that decision-makers are armed with the precise intelligence required to navigate highly competitive and rapidly evolving global markets.

Data provided by Extent Research. Source: https://www.extentresearch.com/atosiban-market

Currently serving as a foundational pillar at Extent Research, Priya operates as the primary driving force behind the firm’s unwavering commitment to analytical excellence. She acts as the vital linchpin within the organization’s comprehensive research pipeline, meticulously reviewing and vetting all incoming data and outgoing insights. Her rigorous quality control guarantees that every single Market Research Report published meets elite industry standards for accuracy, relevance, and clarity. Through her steadfast dedication to precision, she ensures that clients receive reliable, transformative intelligence tailored directly to their long-term strategic needs.

Cross-Industry Expertise

Priya’s exceptional analytical prowess is not confined to a single niche. Rather, she possesses a broad, cross-industry expertise that allows her to expertly decode intricate market shifts and uncover hidden economic patterns. Her ability to synthesize complex technological innovations and sector-specific developments allows her to offer fresh, multifaceted perspectives. She expertly oversees data, forecasts, and emerging trends across an expansive spectrum of global industries, including:

  • Aerospace and Defense
  • Agriculture
  • Automobile & Transportation
  • Chemical & Material
  • Consumer Goods
  • Electronics & Semiconductor
  • Energy & Power
  • Food & Beverages
  • Internet & Communication
  • Machinery & Equipment
  • Medical Care
  • Medical Devices & Consumables
  • New Technology
  • Packaging
  • Pharma & Healthcare
  • Service & Software

Transforming Data into Strategy

By analyzing cross-domain developments across these diverse sectors, Priya effortlessly translates highly technical and complex datasets into digestible, actionable intelligence. She does not merely report static facts; she actively brings the intricate world of market intelligence to life, making it highly engaging and educational for investors, seasoned professionals, and corporate leaders alike.

Her exceptional attention to detail and her innate ability to forecast tomorrow’s emerging innovations keep her and her global clientele consistently one step ahead of the curve. Ultimately, Priya M’s unwavering dedication to precision, combined with her forward-thinking methodology, makes her an indispensable asset to the industry. She guarantees that every piece of strategic advice delivered is backed by rigorous, world-class research.

Domain Assigned: Multiple Sectors